Back to search results

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

IsraelRecruitingPHASE2

Conditions

Multiple Myeloma, Refractory to Standard Treatment · Multiple Myeloma, Relapsed · Light Chain Amyloidosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Hadassah MO, Jerusalem, Israel

    Contact: Study coordinator (Polina Stepensky, Prof.) · Fainak@haddasah.org.il · +97226776679
    Contact: Principal Investigator (Polina Stepensky, prof.)
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)